Optimizing Dysphagia Treatment Delivery in Acute Care: A Hybrid Efficacy Implementation Trial
This research study is investigating the efficacy and implementation of expiratory muscle strength training (EMST), standard of care dysphagia treatment, and intensive dysphagia treatment in critically ill adults in the acute care setting. Currently, no targeted, effective, and feasible dysphagia treatment approaches currently exist for use in critically ill adults in the acute care setting. The current study will investigate the impact of EMST, standard of care dysphagia treatment, and intensive dysphagia treatment on pulmonary function, cough function, swallow function, frailty, patient-reported swallow function, and health outcomes in critically ill adults. This study will also examine patient perceptions and clinical speech-language pathologists' perceptions of the acceptability, appropriateness, and feasibility of these interventions.
Critically ill adults will: undergo tests of breathing, cough, and swallow function, complete questionnaires about the treatment, and their swallow function, and complete their respective treatment as prescribed.
Clinical speech-language pathologists will complete questionnaires about the interventions.
A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
This study will involve two in-person research evaluations in the hospital that will last 45 minutes- 1 hour and will consist of a screening, breathing and cough testing, swallow function testing, measures of frailty, and completion of questionnaires. Following the initial research evaluation, critically ill adults will complete the intervention they are assigned to as prescribed. The exercises will take 15-20 minutes to complete and adherence to treatment will be tracked. Prior to hospital discharge and after completion of the intervention, critically ill adults will undergo a second research evaluation.
Clinical speech-language pathologists will complete questionnaires about the interventions that will take 10-15 minutes.
A subset of critically ill adults and clinical speech-language pathologists will also have the opportunity to participate in focus groups, which will take 45 minutes-1 hour.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Cara Donohue, PhD CCC-SLP
- Puhelinnumero: 615-852-5085
- Sähköposti: cara.donohue@vumc.org
Opiskelupaikat
-
-
Tennessee
-
Nashville, Tennessee, Yhdysvallat, 37232
- Vanderbilt University Medical Center
-
Ottaa yhteyttä:
- Cara Donohue, PhD CCC-SLP
- Puhelinnumero: 615-852-5085
- Sähköposti: cara.donohue@vumc.org
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion criteria for critically ill adults will be:
- Adult ≥ 18 years old
- Not pregnant
- Underwent a clinical flexible endoscopic evaluation of swallowing (FEES) or videofluoroscopy swallow study (VFSS) with a penetration aspiration scale (PAS) score ≥ 5
- Hospitalized in non-neuro intensive care unit (ICU) setting at Vanderbilt University Medical Center (VUMC) at some point during admission
- Dysphagia is primarily related to ICU stay and not other medical conditions that may cause dysphagia
- medically cleared with no contraindications for expiratory muscle strength training (EMST) or other treatments
- Cognitive capacity to follow basic directions
- Willing to undergo testing and treatment for the study.
Inclusion criteria for speech-language pathologists (SLPs) will be:
- Adult acute care speech-language pathologist who works at VUMC.
- Willing to complete surveys and/or participate in a focus group.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Expiratory muscle strength training (EMST)
Critically ill adults will complete EMST as prescribed.
|
EMST devices will be set to 60% of participants' maximum expiratory pressure.
Participants will complete training 5 days per week by performing 5 sets of 5 repetitions.
|
|
Active Comparator: Standard of Care Dysphagia Treatment
Critically ill adults will receive dysphagia treatment per standard of care.
|
Critically ill adults will perform one set of ten repetitions of each exercise recommended by their clinical speech-language pathologist.
Enrolled participants will complete up to two training sessions per week (0-2 pending normal clinical care course) with a clinical speech-language pathologist
|
|
Kokeellinen: Intensive Dysphagia Treatment
Critically ill adults will complete intensive dysphagia treatment as prescribed.
|
Critically ill adults will perform one set of ten repetitions of each exercise (effortful swallow, Masako maneuver, Mendelsohn maneuver, chin tuck against resistance, tongue strengthening exercises, and may also participate in bolus driven therapy).
Enrolled participants will complete five training sessions per week (at least 3 days/week with the PI or a trained member of the research team and up to 2 days/week with a member of the clinical speech-language pathology team).
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) Grades
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
The DIGEST is a validated, 5-point ordinal rating scale that quantifies global pharyngeal swallow function.
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Change in Penetration Aspiration Scale Scores
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
The penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing.
Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in maximum expiratory pressure
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
A measure of respiratory strength while breathing out
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Change in cough peak expiratory flow
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
A measure of cough strength
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Grip strength
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
Change in Grip strength be used to quantify clinical frailty using a digital hand dynamometer.
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Change in Swallowing and Eating Related Fatigue Questionnaire (SERF)
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
Scores on the SERF range 0-48 with higher scores indicating greater impairment.
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Change in Screening for Oral Frailty Tool (SOFT)
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
Oral frailty will be assessed as present/absent using the Screening for Oral Frailty Tool.
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Change in Eating Assessment Tool 10 (EAT-10)
Aikaikkuna: pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
The EAT-10 contains 10 questions (score range: 0-40), higher scores indicate greater impairment.
|
pre-treatment (baseline), and post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Acceptability of Intervention Measure (AIM)
Aikaikkuna: post-treatment prior to hospital discharge, assessed up to 2 weeks
|
A measure of how acceptable an intervention is with scores ranging from 4-20.
|
post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Intervention Appropriateness Measure (IAM)
Aikaikkuna: post-treatment prior to hospital discharge, assessed up to 2 weeks
|
A measure of how appropriate an intervention is with scores ranging from 4-20.
|
post-treatment prior to hospital discharge, assessed up to 2 weeks
|
|
Feasibility of Intervention Measure (FIM)
Aikaikkuna: post-treatment prior to hospital discharge, assessed up to 2 weeks
|
A measure of how feasible an intervention is with scores ranging from 4-20.
|
post-treatment prior to hospital discharge, assessed up to 2 weeks
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: Cara Donohue, PhD CCC-SLP, Vanderbilt University Medical Center
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
- Patologiset prosessit
- Sairauden ominaisuudet
- Hengityselinten sairaudet
- Ruoansulatuskanavan sairaudet
- Ruoansulatuskanavan sairaudet
- Hengityshäiriöt
- Ruokatorven sairaudet
- Otorinolaryngologiset sairaudet
- Merkit ja oireet, Hengityselimet
- Nielun sairaudet
- Patologiset tilat, merkit ja oireet
- Merkit ja oireet
- Kriittinen sairaus
- Hengityshengitys
- Deglutation häiriöt
- Yskä
Muut tutkimustunnusnumerot
- 261042
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .